Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen's FDA Letter Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 20.
1. FDA Claims Six of Qiagen's Artus Dxs Require Approval for Sale in US (from Oct. 17)
2. ABI President Cathy Burzik Steps Down; Applera CEO White Becomes Interim President (from Oct. 20)
3. Sanger and Solexa Use GAS to Sequence X Chromosome; Full Draft Genome Expected by Year End (from Oct. 18)
4. Baylor Researcher Wins $500K NHGRI Grant to Develop Improved SBS Instrument (from Oct. 16)
5. FTC Approves Thermo-Fisher Merger; Fisher to Divest Genevac Business (from Oct. 18)
The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.